Recombinant
RabMAb

Recombinant Anti-PAX8 antibody [EPR13511] - C-terminal (ab189249)

Publishing research using ab189249? Please let us know so that we can cite the reference in this datasheet.

ab189249 has been referenced in 5 publications.

  • Ramalingam H  et al. Disparate levels of beta-catenin activity determine nephron progenitor cell fate. Dev Biol 440:13-21 (2018). IF . PubMed: 29705331
  • Penner-Goeke S  et al. The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples. PLoS Genet 13:e1006707 (2017). FM ; Human . PubMed: 28376088
  • Yamanaka S  et al. Generation of interspecies limited chimeric nephrons using a conditional nephron progenitor cell replacement system. Nat Commun 8:1719 (2017). PubMed: 29170512
  • Chai HJ  et al. PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer. Oncol Lett 14:5871-5875 (2017). PubMed: 29113220
  • Taylor-Harding B  et al. Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS. Oncotarget 6:696-714 (2015). PubMed: 25557169

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up